Abstract

IntroductionIn ARIEL3 (NCT01968213), the poly(adenosine diphosphate-ribose) polymerase inhibitor rucaparib significantly improved progression-free survival versus placebo regardless of biomarker status when used as maintenance treatment for recurrent ovarian cancer. The aim...

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Long-term Outcomes With Ibrutinib Treatment for Patients With Relapsed/Refractory Mantle Cell Lymphoma: A Pooled Analysis of 3 Clinical Trials With Nearly 10 Years of Follow-up.
Martin Dreyling ... Sanjay Deshpande
HemaSphere | VOL. 6
Martin Dreyling, et. al.Martin Dreyling ... Sanjay Deshpande
01 May 2022
O009/#786 Rucaparib vs chemotherapy in patients with advanced, relapsed ovarian cancer and a deleterious brca mutation: efficacy and safety from ariel4, a randomized phase 3 study
...
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society | VOL. 31
, et. al. ...
01 Nov 2021
Abstract PD4-01: First-line veliparib plus carboplatin/paclitaxel in patients with HER2-negative advanced/metastatic gBRCA-associated breast cancer: Planned subgroup analysis from the phase 3 BROCADE3 trial
Banu K Arun ... Bruce A Bach
American Journal of Cancer | VOL. 80
Banu K Arun, et. al.Banu K Arun ... Bruce A Bach
14 Feb 2020
Abstract PR06: ARIEL3: A phase 3, randomized, double-blind study of rucaparib vs placebo following response to platinum-based chemotherapy for recurrent ovarian cancer (OC)
Robert L Coleman ...
Clinical cancer research : an official journal of the American Association for Cancer Research | VOL. 24
Robert L Coleman, et. al.Robert L Coleman ...
01 Aug 2018
View more papers

More From: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society

Paper Title
Journal
Date
Author
Role of secondary cytoreduction in relapsed ovarian cancer
Mariana Carvalho Gouveia ... Mariana Scaranti
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society | VOL. -
Mariana Carvalho Gouveia, et. al.Mariana Carvalho Gouveia ... Mariana Scaranti
31 Jul 2024
Risk factors for vaginal squamous intra-epithelial lesions in women with high-grade cervical lesions
Lu Zhang ... Qing Cong
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society | VOL. -
Lu Zhang, et. al.Lu Zhang ... Qing Cong
31 Jul 2024
Preoperative prediction model of lymph node metastasis in the inguinal and femoral region based on radiomics and artificial intelligence
Haijian Zhou ... Tingting Yao
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society | VOL. -
Haijian Zhou, et. al.Haijian Zhou ... Tingting Yao
31 Jul 2024
Artificial intelligence model for enhancing the accuracy of transvaginal ultrasound in detecting endometrial cancer and endometrial atypical hyperplasia
Ilaria Capasso ... Timothy L Kline
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society | VOL. -
Ilaria Capasso, et. al.Ilaria Capasso ... Timothy L Kline
31 Jul 2024
View more papers